7 May 2010, Lysaker, Norway: Pronova BioPharma ASA (OSE: PRON.OL) reports
further solid progress in the first quarter of 2010, with total revenues of NOK
455.4 million and EBITDA of NOK 185.2 million. Total shipments in the quarter
reached 468 tonnes. The group's position has been further strengthened, as
patents have been granted in Europe for the group's proprietary stripping
technology for the removal of
